Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,562.30
(
0.27%
)
News Focus
News Focus
Post# of 648882
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Tuff-Stuff

Send PM Follow Ignore
Followers 217
Posts 247348
Boards Moderated 2
Alias Born 04/06/2006

Tuff-Stuff

Re: Tuff-Stuff post# 461849

Thursday, 05/17/2012 8:14:40 AM

Thursday, May 17, 2012 8:14:40 AM

Post# of 648882
Plavix, which has brought Bristol-Myers Squibb (BMY) $42.8B over 15 years, loses its patent protection today. In total, 19 drugs are set to relinquish such protection in 2012 - dubbed the year of "pharmageddon" - costing the industry $38.5B. BMY is now pinning its hopes on the yet-to-be-approved blood thinner Eliquis to make up for Plavix

Concentrate, and ASK the 8-Ball!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today